UCB reported 1.31B in Stock for its fiscal semester ending in December of 2024.


Stock Change Date
Alcon AG USD 2.39B 51M Jun/2025
Almirall EUR 180.5M 8.81M Mar/2025
Amarin USD 224M 15.41M Sep/2024
argenx SE USD 340.62M 66.61M Jun/2025
AstraZeneca USD 6.47B 583M Jun/2025
Bayer EUR 12.11B 576M Jun/2025
Galapagos EUR 38.52M 12.67M Mar/2025
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 986M 50M Dec/2024
Lonza CHF 1.73B 13M Dec/2024
Merck EUR 4.47B 45M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Orion EUR 433.4M 14.8M Mar/2025
Recordati EUR 493.63M 5.44M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 9.62B 12.23B Jun/2025
UCB 1.31B 173M Dec/2024
Unibail Rodamco EUR 17.6M 15.1M Dec/2024